Free Trial

Ambev S.A. (NYSE:ABEV) Shares Sold by Cambridge Investment Research Advisors Inc.

Ambev logo with Consumer Staples background

Cambridge Investment Research Advisors Inc. lessened its stake in shares of Ambev S.A. (NYSE:ABEV - Free Report) by 13.6% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 956,263 shares of the company's stock after selling 150,024 shares during the quarter. Cambridge Investment Research Advisors Inc.'s holdings in Ambev were worth $2,228,000 at the end of the most recent quarter.

Several other large investors have also modified their holdings of the stock. GAMMA Investing LLC boosted its holdings in Ambev by 468.4% in the 1st quarter. GAMMA Investing LLC now owns 10,998 shares of the company's stock valued at $26,000 after purchasing an additional 9,063 shares in the last quarter. Generation Capital Management LLC purchased a new stake in Ambev in the 4th quarter valued at approximately $28,000. Naviter Wealth LLC purchased a new stake in Ambev in the 4th quarter valued at approximately $29,000. NewEdge Advisors LLC boosted its holdings in Ambev by 51.4% in the 4th quarter. NewEdge Advisors LLC now owns 17,084 shares of the company's stock valued at $32,000 after purchasing an additional 5,798 shares in the last quarter. Finally, First Trust Advisors LP purchased a new stake in Ambev in the 4th quarter valued at approximately $35,000. Hedge funds and other institutional investors own 8.13% of the company's stock.

Ambev Price Performance

Shares of NYSE:ABEV traded down $0.01 during trading on Friday, hitting $2.49. 8,251,170 shares of the stock were exchanged, compared to its average volume of 30,461,732. Ambev S.A. has a 12-month low of $1.76 and a 12-month high of $2.64. The company has a current ratio of 1.11, a quick ratio of 0.80 and a debt-to-equity ratio of 0.02. The company has a fifty day moving average price of $2.47 and a two-hundred day moving average price of $2.20. The company has a market cap of $39.16 billion, a PE ratio of 15.53, a P/E/G ratio of 2.62 and a beta of 0.74.

Ambev (NYSE:ABEV - Get Free Report) last posted its earnings results on Thursday, May 8th. The company reported $0.04 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.04. Ambev had a return on equity of 14.74% and a net margin of 15.76%. The firm had revenue of $3.92 billion for the quarter, compared to analyst estimates of $22.40 billion. On average, analysts forecast that Ambev S.A. will post 0.18 EPS for the current year.

Ambev Cuts Dividend

The business also recently announced a -- dividend, which will be paid on Thursday, July 17th. Investors of record on Monday, May 19th will be paid a $0.0219 dividend. This represents a yield of 5%. The ex-dividend date is Monday, May 19th. Ambev's payout ratio is currently 68.75%.

Wall Street Analyst Weigh In

ABEV has been the topic of a number of analyst reports. Barclays lifted their price objective on Ambev from $2.00 to $2.50 and gave the company an "equal weight" rating in a report on Monday, May 12th. UBS Group boosted their price target on Ambev from $2.60 to $2.70 and gave the stock a "neutral" rating in a research note on Wednesday, June 4th. Morgan Stanley lowered Ambev from an "equal weight" rating to an "underweight" rating in a research note on Monday, April 7th. Finally, Wall Street Zen assumed coverage on Ambev in a research note on Wednesday, April 23rd. They set a "buy" rating on the stock. One investment analyst has rated the stock with a sell rating, four have given a hold rating and one has given a buy rating to the stock. According to data from MarketBeat.com, Ambev currently has an average rating of "Hold" and a consensus target price of $2.60.

View Our Latest Stock Report on ABEV

Ambev Company Profile

(Free Report)

Ambev SA, through its subsidiaries, engages in the production, distribution, and sale of beer, draft beer, carbonated soft drinks, malt and food, other alcoholic beverages, and non-alcoholic and non-carbonated products in Brazil, Central America and Caribbean, Latin America South, and Canada. It offers beer primarily under the Skol, Brahma, Antarctica, Brahva, Budweiser, Bud Light, Beck, Leffe, Hoegaarden, Balboa ICE, Balboa, Atlas Golden Light, Atlas, Bucanero, Cristal, Mayabe, Presidente, Presidente Light, Brahma Light, Bohemia, The One, Corona, Modelo Especial, Stella Artois, Quilmes Clásica, Paceña, Taquiña, Huari, Becker, Cusqueña, Michelob Ultra, Busch, Pilsen, Ouro Fino, Bud 66, Banks, Deputy, Patricia, Labatt Blue, Alexander Keith's, and Kokanee brands.

Featured Articles

Institutional Ownership by Quarter for Ambev (NYSE:ABEV)

Should You Invest $1,000 in Ambev Right Now?

Before you consider Ambev, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ambev wasn't on the list.

While Ambev currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 “Boring” Mega Cap Stocks to Turn Into Pure Profit
Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines